【Abstract】 Objective The effects and the complications of anhydrous alcohol intra-abdominal coeliac plexus block were studied for treating unresectable pancreatic cancer pain. Methods From Jan.2001 to Sep.2005, 61 patients with severe pancreatic cancer pain and accompanied gastrointestinal tract obstruction were treated by anhydrous alcohol intra-abdominal coeliac plexus block and palliative surgical therapy. Pain-relief, KPS and complications in 3 months after operation were observed. Results The cancer pain in all patients was controlled in one week after the block (P<0.05). KPS was improved (P<0.05). Three months after operation, 45(86.5%) patients were without pain or with only light pain. There were no severe complications. Conclusion Anhydrous alcohol intra-abdominal coeliac plexus block is a method with safe and good effective and less complications for the treatment of pancreatic carcinomatous pain.
Citation:
XIONG Jiongxin,HUANG Peng,TAO Jing,WANG Chunyou,WU Heshui.. Intra-Abdominal Coeliac Plexus Block to Treat Unresectable Pancreatic Cancer Pain. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2006, 13(5): 515-517. doi:
Copy
Copyright © the editorial department of CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY of West China Medical Publisher. All rights reserved
1. |
Wanebo HJ, Vezeridis MP. Pancreatic carcinoma in perspective. A continuing challenge [J]. Cancer, 1996; 78(3 Supple)∶580.
|
2. |
Brennan MF, Moccia RD, Klimstra D. Management of adenocarcinoma of the body and tail of the pancreas [J]. Ann Surg, 1996; 223(5)∶506.
|
3. |
孙 燕, 顾慰萍. 癌症三阶梯止痛指导原则 [M]. 北京: 北京医科大学出版社, 2000∶12~16.
|
4. |
Burris HA III, Moore MJ, Andersen J, et al. Improvements in survival and clinical benefit with gemcitabine as first line therapy for patients with advanced pancreas cancer: a randomized trial [J]. J Clin Oncol, 1997; 15(6) ∶2403.
|
5. |
World Health Organization. Handbook for reporting results of cance treatment. World Health Organization. Genvae, 1976∶16-21.
|
6. |
Kita Y, Tanaka T, Yoshida S, et al. Novel recombinant BCG and DNA-vaccination against tuberculosis in a cynomolgus monkey model [J]. Vaccine, 2005; 23 (17-18)∶2132.
|
7. |
王春友. 重视胰腺癌分期评估及综合治疗的科学抉择 [J]. 中国实用外科杂志, 2004; 24( 5) ∶259.
|
8. |
Storniolo AM, Enas NH, Brown CA, et al. An investigational new drug treatment program for patients with gemcitabine: results for over 3 000 patients with pancreatic carcinoma [J]. Cancer, 1999; 85(6)∶1261.
|
9. |
王 平, 陶 凡, 郑汉光. 腹腔神经阻滞用于晚期癌性疼痛的疗效观察 [J]. 中国疼痛医学杂志, 2003; 9(2)∶117.
|
10. |
Popiela T, Kedra B, Sierzega M, et al. Surgical palliation for pancreatic cancer. The 25-year experience of a single reference centre [J]. Zentralbl Chir, 2002; 127(11)∶965.
|
- 1. Wanebo HJ, Vezeridis MP. Pancreatic carcinoma in perspective. A continuing challenge [J]. Cancer, 1996; 78(3 Supple)∶580.
- 2. Brennan MF, Moccia RD, Klimstra D. Management of adenocarcinoma of the body and tail of the pancreas [J]. Ann Surg, 1996; 223(5)∶506.
- 3. 孙 燕, 顾慰萍. 癌症三阶梯止痛指导原则 [M]. 北京: 北京医科大学出版社, 2000∶12~16.
- 4. Burris HA III, Moore MJ, Andersen J, et al. Improvements in survival and clinical benefit with gemcitabine as first line therapy for patients with advanced pancreas cancer: a randomized trial [J]. J Clin Oncol, 1997; 15(6) ∶2403.
- 5. World Health Organization. Handbook for reporting results of cance treatment. World Health Organization. Genvae, 1976∶16-21.
- 6. Kita Y, Tanaka T, Yoshida S, et al. Novel recombinant BCG and DNA-vaccination against tuberculosis in a cynomolgus monkey model [J]. Vaccine, 2005; 23 (17-18)∶2132.
- 7. 王春友. 重视胰腺癌分期评估及综合治疗的科学抉择 [J]. 中国实用外科杂志, 2004; 24( 5) ∶259.
- 8. Storniolo AM, Enas NH, Brown CA, et al. An investigational new drug treatment program for patients with gemcitabine: results for over 3 000 patients with pancreatic carcinoma [J]. Cancer, 1999; 85(6)∶1261.
- 9. 王 平, 陶 凡, 郑汉光. 腹腔神经阻滞用于晚期癌性疼痛的疗效观察 [J]. 中国疼痛医学杂志, 2003; 9(2)∶117.
- 10. Popiela T, Kedra B, Sierzega M, et al. Surgical palliation for pancreatic cancer. The 25-year experience of a single reference centre [J]. Zentralbl Chir, 2002; 127(11)∶965.